Table 2 Detailed cancer information in ST cases and controls
ST (n = 253) | Controls (n = 1012) | |
|---|---|---|
Cancer | 31 (12.3) | 86 (8.5) |
Cancer type | ||
Bladder | 4 (1.6) | 2 (0.2) |
Brain | 1 (0.4) | 1 (0.1) |
Breast | 1 (0.4) | 4 (0.4) |
Colon | 8 (3.2) | 19 (1.9) |
Esophageal | 2 (0.8) | 1 (0.1) |
Gastric | 6 (2.4) | 14 (1.4) |
Hematopoietic | 0 (0.0) | 4 (0.4) |
Liver | 0 (0.0) | 3 (0.3) |
Lung | 3 (1.2) | 9 (0.9) |
Neck | 1 (0.4) | 2 (0.2) |
Ovarian | 0 (0.0) | 1 (0.1) |
Pancreas | 0 (0.0) | 3 (0.3) |
Prostate | 3 (1.2) | 13 (1.3) |
Rectum | 0 (0.0) | 4 (0.4) |
Renal | 1 (0.4) | 4 (0.4) |
Skin | 0 (0.0) | 2 (0.2) |
Thyroid | 4 (1.6) | 1 (0.1) |
Uterine | 0 (0.0) | 5 (0.5) |
Other | 0 (0.0) | 3 (0.3) |
Cancer stage | ||
I | 7 (2.8) | 26 (2.6) |
II | 3 (1.2) | 11 (1.1) |
III | 2 (0.8) | 3 (0.3) |
IV | 2 (0.8) | 6 (0.6) |
Unknown | 17 (6.7) | 40 (4.0) |
Metastasis | 3 (1.2) | 7 (0.7) |
Treatment | ||
Surgical therapy | 22 (8.7) | 62 (6.1) |
Radiation therapy | 5 (2.0) | 9 (0.9) |
Chemotherapy | 4 (1.6) | 21 (2.1) |
Cisplatin | 2 (0.8) | 3 (0.3) |
Gemcitabine | 0 (0.0) | 3 (0.3) |
Hormone therapy | 2 (0.8) | 7 (0.7) |